nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—ADRA1B—Phendimetrazine—obesity	0.193	0.278	CbGbCtD
Alfuzosin—ADRA1A—Phendimetrazine—obesity	0.152	0.219	CbGbCtD
Alfuzosin—ADRA1A—Benzphetamine—obesity	0.115	0.166	CbGbCtD
Alfuzosin—ADRA1A—Phenylpropanolamine—obesity	0.11	0.158	CbGbCtD
Alfuzosin—CYP3A4—Sibutramine—obesity	0.0335	0.0483	CbGbCtD
Alfuzosin—CYP3A4—Benzphetamine—obesity	0.0254	0.0366	CbGbCtD
Alfuzosin—CYP3A4—Bupropion—obesity	0.0216	0.0311	CbGbCtD
Alfuzosin—CYP3A4—Orlistat—obesity	0.0176	0.0254	CbGbCtD
Alfuzosin—CYP3A4—Cimetidine—obesity	0.0159	0.0228	CbGbCtD
Alfuzosin—CYP3A4—Topiramate—obesity	0.0104	0.015	CbGbCtD
Alfuzosin—Prazosin—SLC22A1—obesity	0.00103	1	CrCbGaD
Alfuzosin—Abdominal pain upper—Bupropion—obesity	0.000498	0.00277	CcSEcCtD
Alfuzosin—Erectile dysfunction—Sibutramine—obesity	0.000498	0.00277	CcSEcCtD
Alfuzosin—Fatigue—Cimetidine—obesity	0.000496	0.00276	CcSEcCtD
Alfuzosin—Breast disorder—Bupropion—obesity	0.000493	0.00274	CcSEcCtD
Alfuzosin—Constipation—Cimetidine—obesity	0.000492	0.00274	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Orlistat—obesity	0.000489	0.00272	CcSEcCtD
Alfuzosin—Urticaria—Diethylpropion—obesity	0.000481	0.00267	CcSEcCtD
Alfuzosin—Dizziness—Phenylpropanolamine—obesity	0.000481	0.00267	CcSEcCtD
Alfuzosin—Diarrhoea—Phentermine—obesity	0.000476	0.00264	CcSEcCtD
Alfuzosin—Feeling abnormal—Cimetidine—obesity	0.000475	0.00264	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Sibutramine—obesity	0.000473	0.00263	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Orlistat—obesity	0.000471	0.00262	CcSEcCtD
Alfuzosin—Sinusitis—Orlistat—obesity	0.000468	0.0026	CcSEcCtD
Alfuzosin—Influenza like illness—Topiramate—obesity	0.000465	0.00258	CcSEcCtD
Alfuzosin—Sweating—Sibutramine—obesity	0.000462	0.00257	CcSEcCtD
Alfuzosin—Vomiting—Phenylpropanolamine—obesity	0.000462	0.00257	CcSEcCtD
Alfuzosin—Dizziness—Phentermine—obesity	0.00046	0.00256	CcSEcCtD
Alfuzosin—Rash—Phenylpropanolamine—obesity	0.000458	0.00255	CcSEcCtD
Alfuzosin—Dermatitis—Phenylpropanolamine—obesity	0.000458	0.00254	CcSEcCtD
Alfuzosin—Bronchitis—Bupropion—obesity	0.000454	0.00252	CcSEcCtD
Alfuzosin—Sinusitis—Sibutramine—obesity	0.000453	0.00251	CcSEcCtD
Alfuzosin—Neuropathy—Topiramate—obesity	0.00045	0.0025	CcSEcCtD
Alfuzosin—Pharyngitis—Orlistat—obesity	0.000444	0.00247	CcSEcCtD
Alfuzosin—Vomiting—Phentermine—obesity	0.000442	0.00246	CcSEcCtD
Alfuzosin—Urinary tract disorder—Orlistat—obesity	0.000442	0.00246	CcSEcCtD
Alfuzosin—Urethral disorder—Orlistat—obesity	0.000439	0.00244	CcSEcCtD
Alfuzosin—Rash—Phentermine—obesity	0.000439	0.00244	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Bupropion—obesity	0.000438	0.00244	CcSEcCtD
Alfuzosin—Dermatitis—Phentermine—obesity	0.000438	0.00244	CcSEcCtD
Alfuzosin—Headache—Phentermine—obesity	0.000436	0.00242	CcSEcCtD
Alfuzosin—Erectile dysfunction—Bupropion—obesity	0.000434	0.00241	CcSEcCtD
Alfuzosin—Rhinitis—Sibutramine—obesity	0.000434	0.00241	CcSEcCtD
Alfuzosin—Nausea—Phenylpropanolamine—obesity	0.000432	0.0024	CcSEcCtD
Alfuzosin—Pharyngitis—Sibutramine—obesity	0.00043	0.00239	CcSEcCtD
Alfuzosin—Infestation NOS—Bupropion—obesity	0.000421	0.00234	CcSEcCtD
Alfuzosin—Infestation—Bupropion—obesity	0.000421	0.00234	CcSEcCtD
Alfuzosin—Diarrhoea—Diethylpropion—obesity	0.000414	0.0023	CcSEcCtD
Alfuzosin—Nausea—Phentermine—obesity	0.000413	0.0023	CcSEcCtD
Alfuzosin—Asthenia—Cimetidine—obesity	0.000413	0.0023	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Bupropion—obesity	0.000412	0.00229	CcSEcCtD
Alfuzosin—Jaundice—Bupropion—obesity	0.00041	0.00228	CcSEcCtD
Alfuzosin—Eye disorder—Sibutramine—obesity	0.000405	0.00225	CcSEcCtD
Alfuzosin—Mediastinal disorder—Orlistat—obesity	0.000403	0.00224	CcSEcCtD
Alfuzosin—Sweating—Bupropion—obesity	0.000403	0.00224	CcSEcCtD
Alfuzosin—Dizziness—Diethylpropion—obesity	0.0004	0.00222	CcSEcCtD
Alfuzosin—Sinusitis—Bupropion—obesity	0.000395	0.00219	CcSEcCtD
Alfuzosin—Diarrhoea—Cimetidine—obesity	0.000394	0.00219	CcSEcCtD
Alfuzosin—Angiopathy—Sibutramine—obesity	0.000393	0.00218	CcSEcCtD
Alfuzosin—Mental disorder—Orlistat—obesity	0.000392	0.00218	CcSEcCtD
Alfuzosin—Vomiting—Diethylpropion—obesity	0.000385	0.00214	CcSEcCtD
Alfuzosin—Rash—Diethylpropion—obesity	0.000382	0.00212	CcSEcCtD
Alfuzosin—Dermatitis—Diethylpropion—obesity	0.000381	0.00212	CcSEcCtD
Alfuzosin—Dizziness—Cimetidine—obesity	0.000381	0.00212	CcSEcCtD
Alfuzosin—Headache—Diethylpropion—obesity	0.000379	0.00211	CcSEcCtD
Alfuzosin—Rhinitis—Bupropion—obesity	0.000378	0.0021	CcSEcCtD
Alfuzosin—Back pain—Orlistat—obesity	0.000377	0.00209	CcSEcCtD
Alfuzosin—Pharyngitis—Bupropion—obesity	0.000375	0.00208	CcSEcCtD
Alfuzosin—Urinary tract disorder—Bupropion—obesity	0.000373	0.00207	CcSEcCtD
Alfuzosin—Connective tissue disorder—Bupropion—obesity	0.000371	0.00206	CcSEcCtD
Alfuzosin—Urethral disorder—Bupropion—obesity	0.00037	0.00206	CcSEcCtD
Alfuzosin—Vomiting—Cimetidine—obesity	0.000366	0.00203	CcSEcCtD
Alfuzosin—Back pain—Sibutramine—obesity	0.000365	0.00203	CcSEcCtD
Alfuzosin—Rash—Cimetidine—obesity	0.000363	0.00202	CcSEcCtD
Alfuzosin—Dermatitis—Cimetidine—obesity	0.000363	0.00202	CcSEcCtD
Alfuzosin—Ill-defined disorder—Orlistat—obesity	0.000361	0.00201	CcSEcCtD
Alfuzosin—Headache—Cimetidine—obesity	0.000361	0.002	CcSEcCtD
Alfuzosin—Nausea—Diethylpropion—obesity	0.000359	0.002	CcSEcCtD
Alfuzosin—Angioedema—Orlistat—obesity	0.000356	0.00198	CcSEcCtD
Alfuzosin—Eye disorder—Bupropion—obesity	0.000353	0.00196	CcSEcCtD
Alfuzosin—Malaise—Orlistat—obesity	0.000351	0.00195	CcSEcCtD
Alfuzosin—Cardiac disorder—Bupropion—obesity	0.00035	0.00195	CcSEcCtD
Alfuzosin—Flushing—Bupropion—obesity	0.00035	0.00195	CcSEcCtD
Alfuzosin—Vertigo—Orlistat—obesity	0.00035	0.00194	CcSEcCtD
Alfuzosin—Ill-defined disorder—Sibutramine—obesity	0.00035	0.00194	CcSEcCtD
Alfuzosin—Osteoarthritis—Topiramate—obesity	0.000348	0.00193	CcSEcCtD
Alfuzosin—Angioedema—Sibutramine—obesity	0.000344	0.00191	CcSEcCtD
Alfuzosin—Palpitations—Orlistat—obesity	0.000344	0.00191	CcSEcCtD
Alfuzosin—Angiopathy—Bupropion—obesity	0.000343	0.0019	CcSEcCtD
Alfuzosin—Nausea—Cimetidine—obesity	0.000342	0.0019	CcSEcCtD
Alfuzosin—Mediastinal disorder—Bupropion—obesity	0.00034	0.00189	CcSEcCtD
Alfuzosin—Malaise—Sibutramine—obesity	0.00034	0.00189	CcSEcCtD
Alfuzosin—Vertigo—Sibutramine—obesity	0.000339	0.00188	CcSEcCtD
Alfuzosin—Syncope—Sibutramine—obesity	0.000338	0.00188	CcSEcCtD
Alfuzosin—Palpitations—Sibutramine—obesity	0.000333	0.00185	CcSEcCtD
Alfuzosin—Chest pain—Orlistat—obesity	0.000332	0.00184	CcSEcCtD
Alfuzosin—Loss of consciousness—Sibutramine—obesity	0.000331	0.00184	CcSEcCtD
Alfuzosin—Mental disorder—Bupropion—obesity	0.000331	0.00184	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000329	0.00183	CcSEcCtD
Alfuzosin—Discomfort—Orlistat—obesity	0.000328	0.00182	CcSEcCtD
Alfuzosin—Dry mouth—Orlistat—obesity	0.000324	0.0018	CcSEcCtD
Alfuzosin—Arthralgia—Sibutramine—obesity	0.000321	0.00178	CcSEcCtD
Alfuzosin—Chest pain—Sibutramine—obesity	0.000321	0.00178	CcSEcCtD
Alfuzosin—Oedema—Orlistat—obesity	0.000318	0.00177	CcSEcCtD
Alfuzosin—Back pain—Bupropion—obesity	0.000318	0.00177	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Topiramate—obesity	0.000318	0.00176	CcSEcCtD
Alfuzosin—Abdominal pain upper—Topiramate—obesity	0.000318	0.00176	CcSEcCtD
Alfuzosin—Discomfort—Sibutramine—obesity	0.000317	0.00176	CcSEcCtD
Alfuzosin—Infection—Orlistat—obesity	0.000316	0.00175	CcSEcCtD
Alfuzosin—Breast disorder—Topiramate—obesity	0.000314	0.00175	CcSEcCtD
Alfuzosin—Dry mouth—Sibutramine—obesity	0.000314	0.00174	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Topiramate—obesity	0.000313	0.00174	CcSEcCtD
Alfuzosin—Nervous system disorder—Orlistat—obesity	0.000312	0.00173	CcSEcCtD
Alfuzosin—Skin disorder—Orlistat—obesity	0.000309	0.00172	CcSEcCtD
Alfuzosin—Oedema—Sibutramine—obesity	0.000308	0.00171	CcSEcCtD
Alfuzosin—Hyperhidrosis—Orlistat—obesity	0.000307	0.00171	CcSEcCtD
Alfuzosin—Infection—Sibutramine—obesity	0.000306	0.0017	CcSEcCtD
Alfuzosin—Ill-defined disorder—Bupropion—obesity	0.000305	0.00169	CcSEcCtD
Alfuzosin—Shock—Sibutramine—obesity	0.000303	0.00168	CcSEcCtD
Alfuzosin—Thrombocytopenia—Sibutramine—obesity	0.000301	0.00167	CcSEcCtD
Alfuzosin—Angioedema—Bupropion—obesity	0.0003	0.00167	CcSEcCtD
Alfuzosin—Tachycardia—Sibutramine—obesity	0.0003	0.00167	CcSEcCtD
Alfuzosin—Skin disorder—Sibutramine—obesity	0.000299	0.00166	CcSEcCtD
Alfuzosin—Hyperhidrosis—Sibutramine—obesity	0.000297	0.00165	CcSEcCtD
Alfuzosin—Malaise—Bupropion—obesity	0.000296	0.00165	CcSEcCtD
Alfuzosin—Vertigo—Bupropion—obesity	0.000295	0.00164	CcSEcCtD
Alfuzosin—Syncope—Bupropion—obesity	0.000295	0.00164	CcSEcCtD
Alfuzosin—Angina pectoris—Topiramate—obesity	0.000293	0.00163	CcSEcCtD
Alfuzosin—Palpitations—Bupropion—obesity	0.00029	0.00161	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Orlistat—obesity	0.00029	0.00161	CcSEcCtD
Alfuzosin—Bronchitis—Topiramate—obesity	0.000289	0.00161	CcSEcCtD
Alfuzosin—Loss of consciousness—Bupropion—obesity	0.000289	0.00161	CcSEcCtD
Alfuzosin—Hypotension—Sibutramine—obesity	0.000288	0.0016	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Sibutramine—obesity	0.00028	0.00156	CcSEcCtD
Alfuzosin—Dyspepsia—Orlistat—obesity	0.00028	0.00155	CcSEcCtD
Alfuzosin—Arthralgia—Bupropion—obesity	0.00028	0.00155	CcSEcCtD
Alfuzosin—Chest pain—Bupropion—obesity	0.00028	0.00155	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Topiramate—obesity	0.000279	0.00155	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000278	0.00154	CcSEcCtD
Alfuzosin—Erectile dysfunction—Topiramate—obesity	0.000277	0.00154	CcSEcCtD
Alfuzosin—Discomfort—Bupropion—obesity	0.000276	0.00154	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Orlistat—obesity	0.000274	0.00153	CcSEcCtD
Alfuzosin—Fatigue—Orlistat—obesity	0.000274	0.00152	CcSEcCtD
Alfuzosin—Dry mouth—Bupropion—obesity	0.000274	0.00152	CcSEcCtD
Alfuzosin—Somnolence—Sibutramine—obesity	0.000274	0.00152	CcSEcCtD
Alfuzosin—Pain—Orlistat—obesity	0.000272	0.00151	CcSEcCtD
Alfuzosin—Dyspepsia—Sibutramine—obesity	0.000271	0.0015	CcSEcCtD
Alfuzosin—Oedema—Bupropion—obesity	0.000268	0.00149	CcSEcCtD
Alfuzosin—Infestation NOS—Topiramate—obesity	0.000268	0.00149	CcSEcCtD
Alfuzosin—Infestation—Topiramate—obesity	0.000268	0.00149	CcSEcCtD
Alfuzosin—Infection—Bupropion—obesity	0.000266	0.00148	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Sibutramine—obesity	0.000266	0.00148	CcSEcCtD
Alfuzosin—Shock—Bupropion—obesity	0.000264	0.00147	CcSEcCtD
Alfuzosin—Constipation—Sibutramine—obesity	0.000263	0.00146	CcSEcCtD
Alfuzosin—Pain—Sibutramine—obesity	0.000263	0.00146	CcSEcCtD
Alfuzosin—Nervous system disorder—Bupropion—obesity	0.000263	0.00146	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Topiramate—obesity	0.000263	0.00146	CcSEcCtD
Alfuzosin—Thrombocytopenia—Bupropion—obesity	0.000263	0.00146	CcSEcCtD
Alfuzosin—Feeling abnormal—Orlistat—obesity	0.000262	0.00146	CcSEcCtD
Alfuzosin—Tachycardia—Bupropion—obesity	0.000262	0.00145	CcSEcCtD
Alfuzosin—Skin disorder—Bupropion—obesity	0.000261	0.00145	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Orlistat—obesity	0.00026	0.00144	CcSEcCtD
Alfuzosin—Hyperhidrosis—Bupropion—obesity	0.000259	0.00144	CcSEcCtD
Alfuzosin—Feeling abnormal—Sibutramine—obesity	0.000254	0.00141	CcSEcCtD
Alfuzosin—Urticaria—Orlistat—obesity	0.000253	0.0014	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Sibutramine—obesity	0.000252	0.0014	CcSEcCtD
Alfuzosin—Sinusitis—Topiramate—obesity	0.000251	0.0014	CcSEcCtD
Alfuzosin—Abdominal pain—Orlistat—obesity	0.000251	0.0014	CcSEcCtD
Alfuzosin—Hypotension—Bupropion—obesity	0.000251	0.00139	CcSEcCtD
Alfuzosin—Urticaria—Sibutramine—obesity	0.000244	0.00136	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Bupropion—obesity	0.000244	0.00136	CcSEcCtD
Alfuzosin—Abdominal pain—Sibutramine—obesity	0.000243	0.00135	CcSEcCtD
Alfuzosin—Rhinitis—Topiramate—obesity	0.000241	0.00134	CcSEcCtD
Alfuzosin—Pharyngitis—Topiramate—obesity	0.000239	0.00133	CcSEcCtD
Alfuzosin—Somnolence—Bupropion—obesity	0.000238	0.00132	CcSEcCtD
Alfuzosin—Urinary tract disorder—Topiramate—obesity	0.000238	0.00132	CcSEcCtD
Alfuzosin—Connective tissue disorder—Topiramate—obesity	0.000236	0.00131	CcSEcCtD
Alfuzosin—Dyspepsia—Bupropion—obesity	0.000236	0.00131	CcSEcCtD
Alfuzosin—Urethral disorder—Topiramate—obesity	0.000236	0.00131	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Bupropion—obesity	0.000232	0.00129	CcSEcCtD
Alfuzosin—Fatigue—Bupropion—obesity	0.000231	0.00128	CcSEcCtD
Alfuzosin—Pain—Bupropion—obesity	0.000229	0.00127	CcSEcCtD
Alfuzosin—Constipation—Bupropion—obesity	0.000229	0.00127	CcSEcCtD
Alfuzosin—Asthenia—Orlistat—obesity	0.000228	0.00127	CcSEcCtD
Alfuzosin—Pruritus—Orlistat—obesity	0.000225	0.00125	CcSEcCtD
Alfuzosin—Eye disorder—Topiramate—obesity	0.000225	0.00125	CcSEcCtD
Alfuzosin—Flushing—Topiramate—obesity	0.000223	0.00124	CcSEcCtD
Alfuzosin—Cardiac disorder—Topiramate—obesity	0.000223	0.00124	CcSEcCtD
Alfuzosin—Feeling abnormal—Bupropion—obesity	0.000221	0.00123	CcSEcCtD
Alfuzosin—Asthenia—Sibutramine—obesity	0.000221	0.00123	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Bupropion—obesity	0.000219	0.00122	CcSEcCtD
Alfuzosin—Angiopathy—Topiramate—obesity	0.000218	0.00121	CcSEcCtD
Alfuzosin—Pruritus—Sibutramine—obesity	0.000218	0.00121	CcSEcCtD
Alfuzosin—Diarrhoea—Orlistat—obesity	0.000218	0.00121	CcSEcCtD
Alfuzosin—Mediastinal disorder—Topiramate—obesity	0.000217	0.0012	CcSEcCtD
Alfuzosin—Urticaria—Bupropion—obesity	0.000213	0.00118	CcSEcCtD
Alfuzosin—Abdominal pain—Bupropion—obesity	0.000212	0.00118	CcSEcCtD
Alfuzosin—Mental disorder—Topiramate—obesity	0.000211	0.00117	CcSEcCtD
Alfuzosin—Diarrhoea—Sibutramine—obesity	0.000211	0.00117	CcSEcCtD
Alfuzosin—Dizziness—Orlistat—obesity	0.00021	0.00117	CcSEcCtD
Alfuzosin—Dizziness—Sibutramine—obesity	0.000203	0.00113	CcSEcCtD
Alfuzosin—Back pain—Topiramate—obesity	0.000203	0.00113	CcSEcCtD
Alfuzosin—Vomiting—Orlistat—obesity	0.000202	0.00112	CcSEcCtD
Alfuzosin—Rash—Orlistat—obesity	0.0002	0.00111	CcSEcCtD
Alfuzosin—Dermatitis—Orlistat—obesity	0.0002	0.00111	CcSEcCtD
Alfuzosin—Headache—Orlistat—obesity	0.000199	0.00111	CcSEcCtD
Alfuzosin—Vomiting—Sibutramine—obesity	0.000196	0.00109	CcSEcCtD
Alfuzosin—Ill-defined disorder—Topiramate—obesity	0.000194	0.00108	CcSEcCtD
Alfuzosin—Rash—Sibutramine—obesity	0.000194	0.00108	CcSEcCtD
Alfuzosin—Dermatitis—Sibutramine—obesity	0.000194	0.00108	CcSEcCtD
Alfuzosin—Headache—Sibutramine—obesity	0.000193	0.00107	CcSEcCtD
Alfuzosin—Asthenia—Bupropion—obesity	0.000192	0.00107	CcSEcCtD
Alfuzosin—Pruritus—Bupropion—obesity	0.00019	0.00105	CcSEcCtD
Alfuzosin—Nausea—Orlistat—obesity	0.000189	0.00105	CcSEcCtD
Alfuzosin—Malaise—Topiramate—obesity	0.000189	0.00105	CcSEcCtD
Alfuzosin—Vertigo—Topiramate—obesity	0.000188	0.00105	CcSEcCtD
Alfuzosin—Syncope—Topiramate—obesity	0.000188	0.00104	CcSEcCtD
Alfuzosin—Palpitations—Topiramate—obesity	0.000185	0.00103	CcSEcCtD
Alfuzosin—Loss of consciousness—Topiramate—obesity	0.000184	0.00102	CcSEcCtD
Alfuzosin—Diarrhoea—Bupropion—obesity	0.000184	0.00102	CcSEcCtD
Alfuzosin—Nausea—Sibutramine—obesity	0.000183	0.00102	CcSEcCtD
Alfuzosin—Arthralgia—Topiramate—obesity	0.000178	0.000991	CcSEcCtD
Alfuzosin—Chest pain—Topiramate—obesity	0.000178	0.000991	CcSEcCtD
Alfuzosin—Dizziness—Bupropion—obesity	0.000177	0.000986	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000177	0.000984	CcSEcCtD
Alfuzosin—Discomfort—Topiramate—obesity	0.000176	0.000979	CcSEcCtD
Alfuzosin—Dry mouth—Topiramate—obesity	0.000174	0.000969	CcSEcCtD
Alfuzosin—Oedema—Topiramate—obesity	0.000171	0.00095	CcSEcCtD
Alfuzosin—Vomiting—Bupropion—obesity	0.000171	0.000948	CcSEcCtD
Alfuzosin—Infection—Topiramate—obesity	0.00017	0.000943	CcSEcCtD
Alfuzosin—Rash—Bupropion—obesity	0.000169	0.00094	CcSEcCtD
Alfuzosin—Dermatitis—Bupropion—obesity	0.000169	0.000939	CcSEcCtD
Alfuzosin—Shock—Topiramate—obesity	0.000168	0.000934	CcSEcCtD
Alfuzosin—Headache—Bupropion—obesity	0.000168	0.000934	CcSEcCtD
Alfuzosin—Nervous system disorder—Topiramate—obesity	0.000168	0.000931	CcSEcCtD
Alfuzosin—Thrombocytopenia—Topiramate—obesity	0.000167	0.00093	CcSEcCtD
Alfuzosin—Tachycardia—Topiramate—obesity	0.000167	0.000927	CcSEcCtD
Alfuzosin—Skin disorder—Topiramate—obesity	0.000166	0.000922	CcSEcCtD
Alfuzosin—Hyperhidrosis—Topiramate—obesity	0.000165	0.000918	CcSEcCtD
Alfuzosin—Hypotension—Topiramate—obesity	0.00016	0.000887	CcSEcCtD
Alfuzosin—Nausea—Bupropion—obesity	0.000159	0.000885	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Topiramate—obesity	0.000156	0.000865	CcSEcCtD
Alfuzosin—Somnolence—Topiramate—obesity	0.000152	0.000844	CcSEcCtD
Alfuzosin—Dyspepsia—Topiramate—obesity	0.00015	0.000836	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Topiramate—obesity	0.000148	0.00082	CcSEcCtD
Alfuzosin—Fatigue—Topiramate—obesity	0.000147	0.000819	CcSEcCtD
Alfuzosin—Constipation—Topiramate—obesity	0.000146	0.000812	CcSEcCtD
Alfuzosin—Pain—Topiramate—obesity	0.000146	0.000812	CcSEcCtD
Alfuzosin—Feeling abnormal—Topiramate—obesity	0.000141	0.000782	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Topiramate—obesity	0.00014	0.000776	CcSEcCtD
Alfuzosin—Urticaria—Topiramate—obesity	0.000136	0.000754	CcSEcCtD
Alfuzosin—Abdominal pain—Topiramate—obesity	0.000135	0.000751	CcSEcCtD
Alfuzosin—Asthenia—Topiramate—obesity	0.000123	0.000681	CcSEcCtD
Alfuzosin—Pruritus—Topiramate—obesity	0.000121	0.000672	CcSEcCtD
Alfuzosin—Diarrhoea—Topiramate—obesity	0.000117	0.00065	CcSEcCtD
Alfuzosin—Dizziness—Topiramate—obesity	0.000113	0.000628	CcSEcCtD
Alfuzosin—Vomiting—Topiramate—obesity	0.000109	0.000604	CcSEcCtD
Alfuzosin—Rash—Topiramate—obesity	0.000108	0.000599	CcSEcCtD
Alfuzosin—Dermatitis—Topiramate—obesity	0.000108	0.000598	CcSEcCtD
Alfuzosin—Headache—Topiramate—obesity	0.000107	0.000595	CcSEcCtD
Alfuzosin—Nausea—Topiramate—obesity	0.000102	0.000564	CcSEcCtD
Alfuzosin—CYP3A4—Metabolism—STS—obesity	1.05e-05	8.41e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—DRD2—obesity	1.04e-05	8.4e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CG—obesity	1.04e-05	8.35e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SOCS1—obesity	1.04e-05	8.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GCG—obesity	1.03e-05	8.31e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTPN1—obesity	1.03e-05	8.31e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CD—obesity	1.03e-05	8.27e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SOCS3—obesity	1.03e-05	8.24e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARD—obesity	1.02e-05	8.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PRKCD—obesity	1.01e-05	8.15e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CD—obesity	1.01e-05	8.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GNB3—obesity	1e-05	8.07e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC27A1—obesity	1e-05	8.06e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HTR2A—obesity	9.93e-06	7.98e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—C3—obesity	9.91e-06	7.97e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—TYK2—obesity	9.89e-06	7.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—POMC—obesity	9.89e-06	7.95e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CB—obesity	9.87e-06	7.94e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRL—obesity	9.87e-06	7.93e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF2—obesity	9.86e-06	7.92e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GLUL—obesity	9.83e-06	7.9e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—FABP4—obesity	9.83e-06	7.9e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—RHOA—obesity	9.81e-06	7.89e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—GNAS—obesity	9.77e-06	7.85e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—STK11—obesity	9.72e-06	7.82e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3R1—obesity	9.71e-06	7.81e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CCL2—obesity	9.68e-06	7.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PLG—obesity	9.61e-06	7.73e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—RHOA—obesity	9.6e-06	7.72e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOB—obesity	9.57e-06	7.69e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT2—obesity	9.51e-06	7.64e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3R1—obesity	9.5e-06	7.64e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IRS2—obesity	9.43e-06	7.58e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AGT—obesity	9.42e-06	7.57e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FOXO3—obesity	9.38e-06	7.54e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ADRB2—obesity	9.36e-06	7.52e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL5—obesity	9.34e-06	7.51e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—UCP3—obesity	9.32e-06	7.49e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ECHS1—obesity	9.32e-06	7.49e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—UCP2—obesity	9.32e-06	7.49e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HSD11B1—obesity	9.32e-06	7.49e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—LEP—obesity	9.23e-06	7.42e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOE—obesity	9.23e-06	7.42e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SOCS1—obesity	9.22e-06	7.41e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ADH1B—obesity	9.17e-06	7.37e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CAV1—obesity	9.14e-06	7.35e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LPL—obesity	9.14e-06	7.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CD—obesity	9.14e-06	7.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APOA1—obesity	9.12e-06	7.33e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SOCS3—obesity	9.11e-06	7.32e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FOXO1—obesity	9.07e-06	7.29e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RPS6KB1—obesity	9.05e-06	7.28e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GPAM—obesity	9.03e-06	7.26e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ACSL1—obesity	9.03e-06	7.26e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARGC1B—obesity	9.03e-06	7.26e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CB—obesity	8.97e-06	7.21e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GNB3—obesity	8.91e-06	7.17e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ESR1—obesity	8.81e-06	7.08e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—TYK2—obesity	8.79e-06	7.07e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CB—obesity	8.77e-06	7.05e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PCK1—obesity	8.76e-06	7.04e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HADH—obesity	8.76e-06	7.04e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—FADS1—obesity	8.76e-06	7.04e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF2—obesity	8.75e-06	7.04e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—RHOA—obesity	8.72e-06	7.01e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PRKCB—obesity	8.7e-06	6.99e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—F2—obesity	8.7e-06	6.99e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—GNAS—obesity	8.68e-06	6.98e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3R1—obesity	8.63e-06	6.93e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—BAD—obesity	8.6e-06	6.91e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ACP5—obesity	8.52e-06	6.85e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOB—obesity	8.5e-06	6.83e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKCD—obesity	8.42e-06	6.77e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CG—obesity	8.33e-06	6.69e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—G6PD—obesity	8.31e-06	6.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL5—obesity	8.3e-06	6.67e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HTR2A—obesity	8.24e-06	6.62e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IRS1—obesity	8.23e-06	6.62e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—C3—obesity	8.23e-06	6.61e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HK1—obesity	8.21e-06	6.6e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SREBF2—obesity	8.21e-06	6.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LPL—obesity	8.12e-06	6.52e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FOXO1—obesity	8.06e-06	6.48e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RPS6KB1—obesity	8.04e-06	6.47e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CB—obesity	7.96e-06	6.4e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—POMC—obesity	7.93e-06	6.37e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPA—obesity	7.92e-06	6.37e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—INS—obesity	7.88e-06	6.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IRS2—obesity	7.83e-06	6.29e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AGT—obesity	7.82e-06	6.28e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CCL2—obesity	7.76e-06	6.23e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPIN1—obesity	7.76e-06	6.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOE—obesity	7.66e-06	6.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—LEP—obesity	7.66e-06	6.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IGF1—obesity	7.62e-06	6.13e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT2—obesity	7.62e-06	6.12e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA5—obesity	7.6e-06	6.11e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CAV1—obesity	7.59e-06	6.1e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APOA1—obesity	7.57e-06	6.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCD—obesity	7.48e-06	6.01e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CD—obesity	7.32e-06	5.88e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HTR2A—obesity	7.32e-06	5.88e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ESR1—obesity	7.31e-06	5.88e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—C3—obesity	7.31e-06	5.87e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CA—obesity	7.25e-06	5.83e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CLOCK—obesity	7.25e-06	5.83e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC22A1—obesity	7.25e-06	5.83e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SERPINE1—obesity	7.24e-06	5.82e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—F2—obesity	7.22e-06	5.81e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PRKCB—obesity	7.22e-06	5.81e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—BAD—obesity	7.14e-06	5.74e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SULT2A1—obesity	7.06e-06	5.68e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GLP1R—obesity	7.06e-06	5.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TYK2—obesity	7.04e-06	5.66e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RHOA—obesity	6.98e-06	5.61e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IRS2—obesity	6.95e-06	5.59e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—DPYD—obesity	6.95e-06	5.59e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AGT—obesity	6.94e-06	5.58e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3R1—obesity	6.91e-06	5.56e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOS3—obesity	6.91e-06	5.56e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CG—obesity	6.91e-06	5.56e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IRS1—obesity	6.83e-06	5.49e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOE—obesity	6.8e-06	5.47e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—LEP—obesity	6.8e-06	5.47e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CAV1—obesity	6.74e-06	5.42e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APOA1—obesity	6.72e-06	5.41e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PRKAR2B—obesity	6.69e-06	5.38e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—DCN—obesity	6.64e-06	5.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CA—obesity	6.58e-06	5.29e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—POMC—obesity	6.58e-06	5.29e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—INS—obesity	6.54e-06	5.26e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ESR1—obesity	6.49e-06	5.22e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CPT1A—obesity	6.46e-06	5.19e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CCL2—obesity	6.44e-06	5.17e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PRKCB—obesity	6.42e-06	5.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—F2—obesity	6.42e-06	5.16e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MTOR—obesity	6.38e-06	5.13e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CB—obesity	6.38e-06	5.13e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—BAD—obesity	6.34e-06	5.1e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NAMPT—obesity	6.34e-06	5.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IGF1—obesity	6.33e-06	5.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT2—obesity	6.32e-06	5.08e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LIPC—obesity	6.3e-06	5.06e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GCK—obesity	6.3e-06	5.06e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOC3—obesity	6.26e-06	5.03e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CG—obesity	6.14e-06	4.93e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CD—obesity	6.08e-06	4.88e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CETP—obesity	6.07e-06	4.88e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IRS1—obesity	6.07e-06	4.88e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	6.02e-06	4.84e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SERPINE1—obesity	6.01e-06	4.83e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SDC1—obesity	6.01e-06	4.83e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AKT1—obesity	5.92e-06	4.76e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKR1C3—obesity	5.91e-06	4.75e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TYK2—obesity	5.85e-06	4.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—POMC—obesity	5.84e-06	4.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL6—obesity	5.83e-06	4.69e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SCARB1—obesity	5.82e-06	4.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—INS—obesity	5.81e-06	4.67e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RHOA—obesity	5.8e-06	4.66e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3R1—obesity	5.74e-06	4.61e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOS3—obesity	5.74e-06	4.61e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CCL2—obesity	5.72e-06	4.6e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SREBF1—obesity	5.65e-06	4.54e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IGF1—obesity	5.62e-06	4.52e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT2—obesity	5.62e-06	4.52e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP9—obesity	5.55e-06	4.46e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GOT2—obesity	5.49e-06	4.42e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CA—obesity	5.47e-06	4.39e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CD—obesity	5.4e-06	4.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MAPK8—obesity	5.39e-06	4.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AKT1—obesity	5.38e-06	4.32e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—FASN—obesity	5.38e-06	4.32e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—BCHE—obesity	5.35e-06	4.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	5.35e-06	4.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SERPINE1—obesity	5.34e-06	4.29e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MTOR—obesity	5.3e-06	4.26e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CB—obesity	5.3e-06	4.26e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TYK2—obesity	5.19e-06	4.17e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP2E1—obesity	5.16e-06	4.15e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RHOA—obesity	5.15e-06	4.14e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NQO1—obesity	5.11e-06	4.11e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3R1—obesity	5.1e-06	4.1e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOS3—obesity	5.1e-06	4.1e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—STAT3—obesity	4.93e-06	3.96e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AKT1—obesity	4.92e-06	3.95e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GCG—obesity	4.9e-06	3.94e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC2A4—obesity	4.9e-06	3.94e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CA—obesity	4.85e-06	3.9e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL6—obesity	4.84e-06	3.89e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYCS—obesity	4.83e-06	3.88e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GGT1—obesity	4.74e-06	3.81e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GOT1—obesity	4.74e-06	3.81e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CB—obesity	4.7e-06	3.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MTOR—obesity	4.7e-06	3.78e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NCOA1—obesity	4.67e-06	3.75e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP9—obesity	4.6e-06	3.7e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP19A1—obesity	4.6e-06	3.7e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—STK11—obesity	4.6e-06	3.7e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MYC—obesity	4.58e-06	3.68e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TGFB1—obesity	4.57e-06	3.67e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MAPK8—obesity	4.48e-06	3.6e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AKT1—obesity	4.46e-06	3.59e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AKT1—obesity	4.37e-06	3.51e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL6—obesity	4.3e-06	3.46e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—COMT—obesity	4.28e-06	3.44e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GNB3—obesity	4.22e-06	3.39e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARGC1A—obesity	4.22e-06	3.39e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—HMOX1—obesity	4.2e-06	3.38e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GNAS—obesity	4.11e-06	3.3e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—STAT3—obesity	4.09e-06	3.29e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP9—obesity	4.09e-06	3.29e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOB—obesity	4.02e-06	3.23e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MAPK8—obesity	3.98e-06	3.2e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT1—obesity	3.97e-06	3.19e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CA—obesity	3.89e-06	3.13e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—LPL—obesity	3.84e-06	3.09e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MYC—obesity	3.8e-06	3.06e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TGFB1—obesity	3.79e-06	3.05e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GPX1—obesity	3.75e-06	3.01e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CD36—obesity	3.65e-06	2.93e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—STAT3—obesity	3.64e-06	2.92e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—MTHFR—obesity	3.46e-06	2.78e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL6—obesity	3.44e-06	2.77e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARA—obesity	3.39e-06	2.73e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MYC—obesity	3.38e-06	2.72e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TGFB1—obesity	3.37e-06	2.71e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AGT—obesity	3.29e-06	2.64e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CA—obesity	3.23e-06	2.6e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOE—obesity	3.22e-06	2.59e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CAV1—obesity	3.19e-06	2.56e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APOA1—obesity	3.18e-06	2.56e-05	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT1—obesity	3.18e-06	2.55e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CG—obesity	2.91e-06	2.34e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.87e-06	2.31e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL6—obesity	2.86e-06	2.3e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARG—obesity	2.81e-06	2.25e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—POMC—obesity	2.77e-06	2.22e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—INS—obesity	2.75e-06	2.21e-05	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT1—obesity	2.64e-06	2.12e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CD—obesity	2.55e-06	2.05e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL6—obesity	2.54e-06	2.04e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ALB—obesity	2.52e-06	2.03e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3R1—obesity	2.41e-06	1.94e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NOS3—obesity	2.41e-06	1.94e-05	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT1—obesity	2.34e-06	1.88e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CB—obesity	2.23e-06	1.79e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—obesity	2.21e-06	1.77e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CA—obesity	1.36e-06	1.09e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKT1—obesity	1.11e-06	8.91e-06	CbGpPWpGaD
